Tecotabart Biosimilar - Research Grade

Human

CLDN18ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P56856

Blue ice

Claudin-18 (CLDN18), particularly its isoform 2, is a tight-junction protein aberrantly exposed in gastric and pancreatic cancers, drawing strong interest as a tumor-targeting antigen. This product is an unconjugated, non-therapeutic analog of tecotabart, a recombinant anti-claudin-18 monoclonal antibody for research use only. Manufactured to in vivo standards with low endotoxin, it is available in scalable milligram to gram quantities for high-throughput laboratories. The antibody is useful for claudin-18-binding functional assays, in vitro tumor-cell screening, and in vivo targeting models. Reproducible, high-purity preparation supports reliable results across repeated and large-scale experiments. Its scalable supply and batch consistency suit programs that require uniform reagent across many studies.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks